Bellicum Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update
Company updates BPX-501 program Enrollment progressing in early clinical trials of CAR T and TCR product candidates Company to host conference call and webcast on August 8 at 5:00 PM EDT HOUSTON, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, …